A NOVEL CONDITIONING REGIMEN WITH ALKYLATING AGENTS, VENETOCLAX, CYTARABINE, CLADRIBINE, AND DECITABINE (ADVANCED) FOR UPFRONT ALLOGENEIC STEM CELL TRANSPLANTATION IN ADVERSE-RISK ACUTE MYELOID LEUKEMIA PATIENTS
EHA Library, Andrius Žučenka,
4162464
EFFICACY AND SAFETY OF THE TBF/ATG/CYCLOPHOSPHAMIDE COMBINED CONDITIONING REGIMEN IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ELDERLY PATIENTS WITH HEMATOLOGIC DISORDERS: INTERIM ANALYSIS OF A SINGLE-CENTER, SINGLE-ARM, PROSPECTIVE PHASE 2 STUDY
EHA Library, Ping Zhang,
4162519
RKER-050, A MODIFIED ACTIVIN RECEPTOR TYPE IIA LIGAND TRAP, REGULATED OSTEOGENIC LINEAGE, COMPLEMENTING THE ERYTHROID RESPONSE AND REBALANCING THE OSTEO-HEMATOPOIETIC NICHE
EHA Library, Vamsee Dhar Myneni,
4162534
INCIDENCE, CLINICAL CHARACTERISTICS, AND RISK FACTORS OF IMMUNE EFFECTOR CELL (IEC) ASSOCIATED HLH-LIKE SYNDROME (IEC-HS) IN PATIENTS TREATED WITH TALICABTAGENE AUTOLEUCEL (HUMANIZED ANTI-CD19 CAR-T)
EHA Library, Hema Hotchandani,
4162553